✦ LIBER ✦

Effect of treatment on clinical trials: Chemoembolization

✍ Scribed by Dr. Paolo Pavone; Marco Castrucci; Carlo Catalano; Luca Marsili; Giorgio Albertini Petroni; Stefania Sanvito; Marco Salviani

Publisher: John Wiley and Sons
Year: 1993
Tongue: English
Weight: 440 KB
Volume: 53
Category: Article
ISSN: 0022-4790
DOI: 10.1002/jso.2930530524

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Effects of treatments in clinical trials

Effects of treatments in clinical trials: Surgery

✍ Dr. Thorkild I. A. Sørensen 📂 Article 📅 1993 🏛 John Wiley and Sons 🌐 English ⚖ 309 KB 👁 1 views

The results of surgery for liver cancer (resection or transplantion) have so far been evaluated against older retrospective reports of the survival of series of patients left untreated. Even though it has been taken for granted that "surgical therapy offers the only chance of cure," the validity of

Generalized treatment effects for clinic

Generalized treatment effects for clinical trials

✍ Walter W. Hauck; Terry Hyslop; Sharon Anderson 📂 Article 📅 2000 🏛 John Wiley and Sons 🌐 English ⚖ 115 KB 👁 1 views

Practice in the analysis of clinical trials with continuously measured endpoints is to focus on the di!erence or percentage change in mean or median response. However, treatments may have e!ects on the distribution of responses other than on the average response. We sought an approach to such genera

Assessing Treatment Effect Heterogeneity

Assessing Treatment Effect Heterogeneity in Clinical Trials with Blocked Binary Outcomes

✍ Jeffrey M. Albert; Gary L. Gadbury; Edward J. Mascha 📂 Article 📅 2005 🏛 John Wiley and Sons 🌐 English ⚖ 176 KB 👁 2 views

This paper addresses treatment effect heterogeneity (also referred to, more compactly, as 'treatment heterogeneity') in the context of a controlled clinical trial with binary endpoints. Treatment heterogeneity, variation in the true (causal) individual treatment effects, is explored using the concep

The effect of preoperative transarterial

The effect of preoperative transarterial chemoembolization of resectable hepatocellular carcinoma on clinical and economic outcomes

✍ King-Teh Lee; Yi-Wei Lu; Shen-Nien Wang; Hong-Yaw Chen; Shih-Chang Chuang; Wen-T 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 141 KB

## Abstract ## Background Hepatocellular carcinoma (HCC) is one of the most malignant cancers in the world. The effect of preoperative transarterial chemoembolization (TACE) for resectable HCC is still controversial and cost‐associated treatments are unknown. ## Methods We retrospectively compar

Comparison of mania patients suitable fo

Comparison of mania patients suitable for treatment trials versus clinical treatment

✍ Alessandra Talamo; Ross J. Baldessarini; Franca Centorrino 📂 Article 📅 2008 🏛 John Wiley and Sons 🌐 English ⚖ 95 KB 👁 1 views

## Abstract It remains uncertain whether bipolar disorder (BPD) patients in randomized‐controlled trials (RCTs) are sufficiently representative of clinically encountered patients as to guide clinical‐therapeutic practice. We complied inclusion/exclusion criteria by frequency from reports of 21 RCTs

ANALYSIS OF UNCONTROLLED TREATMENT CHANG

ANALYSIS OF UNCONTROLLED TREATMENT CHANGES IN HIV CLINICAL TRIALS

✍ HUNG-MO LIN; MICHAEL D. HUGHES 📂 Article 📅 1996 🏛 John Wiley and Sons 🌐 English ⚖ 885 KB

Some clinical trials involving subjects with the human immunodeficiency virus (HIV) allow a subject to change treatment when a marker of disease progression, for example, the CD4 cell count, falls below a defined threshold. Although the change does not involve a randomized control, there is consider